Federal contractor · NEW YORK, NY

ADVANCED ACCELERATOR APPLICATIONS USA INC

ADVANCED ACCELERATOR APPLICATIONS USA INC received -$10.3M in federal contract obligations in FY2026, on 24 awards (−181% vs FY2025). Since FY2017: $84.8M. Its largest customer was National Institutes of Health (-$187.6K).

Obligations · FY2026
-$10.3M
New awards
24
Sole-source
—
Single offer
—
UEI
JNM4NBNHFE66
Parent company
NOVARTIS SANIERUNGSSTIFTUNG
Small businessForeign-owned
Open in the contracts explorerRelationship graph

Company family

Grouped from reported parent companies (UEI) and, where marked, AI judgments that two records name the same organization or group.

2 registered entities of the same company or corporate group, $25.8M in FY2026 together.

  1. ADVANCED ACCELERATOR APPLICATIONS USA INCNEW YORK, NY · Family page
    -$10.3M
  2. NOVARTIS PHARMACEUTICALS CORPORATIONEAST HANOVER, NJ
    $36.2M

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 204KFY2017
  2. 1.3MFY2018
  3. 5.5MFY2019
  4. 8MFY2020
  5. 6.6MFY2021
  6. 7.8MFY2022
  7. 21.7MFY2023
  8. 31.3MFY2024
  9. 12.7MFY2025
  10. -10.3MFY2026

Top buying agencies

Obligations in FY2026.

  1. National Institutes of Health-$187.6K0.0%
    2 awards
  2. Department of Veterans Affairs-$10.1M0.0%
    22 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Where the work was performed

  1. Shawnee County, KS$1.4M0.0%

Integrity signals

Shares of the year's obligations, next to the country's.

Largest awards

  1. PLUVICTO AND LUTATHERA FY 25$3.5M
    Department of Veterans Affairs· Essex County, NJ· Health & medical· Oct 28, 2024 – Mar 23, 2026· 36C26225F0024
  2. LUTETIUM - PLUVICTO AND LUTATHERA$2.9M
    Department of Veterans Affairs· Morris County, NJ· Health & medical· Dec 20, 2024 – Dec 22, 2025· 36C25025N0272
  3. PLUVICTO PROSTATE CANCER TREATMENT$1.8M
    Department of Veterans Affairs· Essex County, NJ· Health & medical· Oct 1, 2023 – May 1, 2026· 36C26124N0090
  4. PLUVICTO PROSTATE CANCER THERAPY VANCHCS$1.7M
    Department of Veterans Affairs· Essex County, NJ· Health & medical· Oct 1, 2024 – Apr 9, 2026· 36C26125F0002
  5. PLUVICTO AND LUTATHERA$1.4M
    Department of Veterans Affairs· Shawnee County, KS· Health & medical· Feb 17, 2025 – Feb 25, 2026· 36C25525N0176
  6. PLUVICTO AND LUTATHERA$1.2M
    Department of Veterans Affairs· Shawnee County, KS· Health & medical· Jan 13, 2026 – Jan 13, 2026· 36C25526N0132
  7. PLUVICTO RADIOPHARM$1.1M
    Department of Veterans Affairs· Cook County, IL· Health & medical· Nov 1, 2024 – Jun 26, 2026· 36C25225F0020
  8. PLUVICTO? (LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN)$1.1M
    Department of Veterans Affairs· Morris County, NJ· Health & medical· Oct 1, 2024 – Sep 23, 2026· 36C26125F0023

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 4 markets (agency × industry), FY2024–FY2026.

  1. PROGENICS PHARMACEUTICALS INC$102.4M+15% in FY2026
    NORTH BILLERICA, MA · 3 entities · 92% of this company's obligations are in markets they both serveVeterans Affairs · Pharmaceutical and medicine manufacturingArmy · Pharmaceutical and medicine manufacturingDefense Health Agency · Pharmaceutical and medicine manufacturing
  2. BIOMERIEUX INC$127.2M+8% in FY2026
    SALT LAKE CITY, UT · 84% of this company's obligations are in markets they both serveVeterans Affairs · Pharmaceutical and medicine manufacturingDefense Health Agency · Pharmaceutical and medicine manufacturingArmy · Pharmaceutical and medicine manufacturing
  3. EXELAN PHARMACEUTICALS INC$179.9M+38% in FY2026
    BOCA RATON, FL · 88% of this company's obligations are in markets they both serveVeterans Affairs · Pharmaceutical and medicine manufacturing

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026 · FY2024–FY2026.

Lobbying and PAC activity

Organizations in House lobbying disclosures and FEC records whose names an AI judgment matched to this company. Those records carry no identifier shared with contracts, so every match is by name.

Across the company family of ADVANCED ACCELERATOR APPLICATIONS USA INC (2 recipients).

Matched organizations

  • NOVARTIS CORPORATIONAI match · 100%
Lobbying · 2025
$7.8M
23 reports
Lobbying · 2023–2026
$24.8M
$24.8M in its own reports
PAC giving · 2026
$313K
1 PAC

Lobbying by year

  1. 2023$5.7M
    16 reports
  2. 2024$6M
    17 reports
  3. 2025$7.8M
    23 reports
  4. 2026$5.3M
    10 reports

Top issues

  1. Health issues58 reports
  2. Medicare and Medicaid57 reports
  3. Trade (domestic and foreign)46 reports
  4. Taxation and the Internal Revenue Code33 reports
  5. Budget and appropriations28 reports
  6. Copyright, patent and trademark28 reports
  7. Labor issues, antitrust and workplace14 reports
  8. Pharmacy4 reports

Who was contacted

  1. U.S. SENATE66 reports
  2. U.S. HOUSE OF REPRESENTATIVES61 reports
  3. Health & Human Services - Dept of (HHS)28 reports
  4. Executive Office of the President (EOP)21 reports
  5. Centers For Medicare and Medicaid Services (CMS)14 reports
  6. Commerce - Dept of (DOC)14 reports
  7. Food & Drug Administration (FDA)14 reports
  8. Office of Management & Budget (OMB)14 reports
  9. Patent & Trademark Office (PTO)14 reports
  10. U.S. Trade Representative (USTR)14 reports

Houses of Congress and federal agencies the reports list as contacted (a report names every one for all its issues).

Lobbying firms hired

  1. Tiber Creek Group$840K
    14 reports
  2. Todd Strategy Group$760K
    14 reports
  3. Forbes-Tate$700K
    14 reports
  4. Thorn Run Partners$190K
    5 reports
  5. B HALL STRATEGIES, LLC$150K
    5 reports

Registrants who are individuals are counted, not named.

PAC giving to candidates by party, 2026 cycle

  1. Republican$157.5K50%
  2. Democratic$155.5K50%

PACs sponsored

  • NOVARTIS CORPORATION POLITICAL ACTION COMMITTEE$527.5K raised this cycle

PACs these organizations sponsor (connected organizations in FEC records). A PAC gives employees' and members' voluntary contributions, not the company's own money.

Lobbying amounts are the filers' own good-faith estimates on quarterly LD-2 reports (the law asks for amounts rounded to $10,000; under $5,000 need not be itemized), latest amendment only. When an organization files its own report, it replaces what outside firms report for it that quarter. Matches are by name. Lobbying and political giving are legal and public: they show engagement with government, not influence over any award. Correlation is not influence: these organizations' lobbying and their contracts are shown side by side, and nothing here implies either affected the other.

Source: Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives), data current to Oct 9, 2026, loaded Oct 9, 2026 · 2023–2026.

Source: Committees, candidates and committee contributions to candidates (Federal Election Commission), data current to Oct 9, 2026, loaded Oct 9, 2026 · 2026, 2024, 2022.

Matches: Analisa AI name judgments (entity-match@1), updated Sep 30, 2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.